---
title: "MassRoots (OTCMKTS:MSRT) Stock Price Up 1%  - What's Next?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278817542.md"
description: "MassRoots (OTCMKTS:MSRT) shares rose 1% to $3.94, with a market cap of $1.97 billion and a P/E ratio of 394.00. Trading volume was significantly lower at 6,971 shares compared to the average of 1,063,234. The company operates a social networking platform for the cannabis industry and has expanded into B2B solutions. Analysts currently rate the stock as a Hold, suggesting there are better investment options available."
datetime: "2026-03-12T04:11:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278817542.md)
  - [en](https://longbridge.com/en/news/278817542.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278817542.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/278817542.md) | [繁體中文](https://longbridge.com/zh-HK/news/278817542.md)


# MassRoots (OTCMKTS:MSRT) Stock Price Up 1%  - What's Next?

MassRoots, Inc. (OTCMKTS:MSRT - Get Free Report)'s share price traded up 1% on Wednesday . The company traded as high as $3.95 and last traded at $3.94. 6,971 shares changed hands during trading, a decline of 99% from the average session volume of 1,063,234 shares. The stock had previously closed at $3.90.

## MassRoots Price Performance

The firm has a market capitalization of $1.97 billion, a price-to-earnings ratio of 394.00 and a beta of 2.45. The firm has a 50 day moving average price of $4.47 and a 200-day moving average price of $5.99.

## About MassRoots

(Get Free Report)

MassRoots, Inc is a U.S.-based technology company that serves the regulated cannabis industry through a consumer-focused social networking platform. The company's flagship mobile application enables cannabis users to discover and share information about strains, dispensaries and related products. Through user-generated reviews, photos and geotagging, MassRoots provides a community forum where enthusiasts, brands and retailers can engage in an age-restricted digital environment tailored to the evolving legal cannabis market.

In addition to its consumer app, MassRoots has expanded into the business-to-business segment with software solutions designed for dispensaries and cannabis growers.

## Read More

-   Five stocks we like better than MassRoots
-   The gold chart Wall Street is terrified of…
-   What a Former CIA Agent Knows About the Coming Collapse
-   Elon Musk already made me a “wealthy man”
-   Unlocked: Elon Musk’s Next Big IPO
-   1,500 Banks Just Handed the Fed Your Bank Account

_This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com._

## Should You Invest $1,000 in MassRoots Right Now?

Before you consider MassRoots, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MassRoots wasn't on the list.

While MassRoots currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

## Related News & Research

- [Vireo Growth Closes Eaze Deal, Expands Cannabis Footprint to 10 States](https://longbridge.com/en/news/281418680.md)
- [Avicanna Strengthens Board as It Targets Global Cannabinoid Growth](https://longbridge.com/en/news/281802074.md)
- [Cresco Labs Awarded Texas Medical Cannabis License | CRLBF Stock News](https://longbridge.com/en/news/281563592.md)
- [New Survey Reveals About Cannabis-Related Health Risks](https://longbridge.com/en/news/281235535.md)
- [A Look At Green Thumb Industries (CNSX:GTII) Valuation After Reshaping RYTHM Royalty Economics](https://longbridge.com/en/news/281701810.md)